Distribution of cultured and molecular positivity in uresponsive and responsive pateints.

<p>Distribution of cultured and molecular positivity in uresponsive and responsive pateints.</p

Odds ratios for potential demographical risk factors with anthroponotic cutaneous leishmaniasis in southeastern Iran.

<p>Odds ratios for potential demographical risk factors with anthroponotic cutaneous leishmaniasis in southeastern Iran.</p

Odds ratios for potential clinical status risk factors with anthroponotic cutaneous leishmaniasis in southeastern Iran.

<p>Odds ratios for potential clinical status risk factors with anthroponotic cutaneous leishmaniasis in southeastern Iran.</p

Set of applied primer to amplify candidate loci with optimum PCR conditions.

<p>Set of applied primer to amplify candidate loci with optimum PCR conditions.</p

Odds ratios for potential environmental risk factors with anthroponotic cutaneous leishmaniasis in southeastern Iran.

<p>Odds ratios for potential environmental risk factors with anthroponotic cutaneous leishmaniasis in southeastern Iran.</p

Baseline characteristics of study participants.

<p>Baseline characteristics of study participants.</p

Age and sex distributions of opium addicted and non – addicted cohorts.

<p>*There was no significant difference among the opium addicted and non-addicted with respect to age or gender.</p

Kaplan-Meier survival estimates of cutaneous leishmaniasis in opium and opium non-addicted.

<p>Kaplan-Meier survival estimates of cutaneous leishmaniasis in opium and opium non-addicted.</p

The incidence of cutaneous leishmaniasis cases in opium addicted and non – addicted cohorts by the year of contraction.

<p><b>*</b>There was no significant difference between the incidence rates among the two cohorts.</p

Location of the cutaneous leishmaniasis lesions in opium addicted and opium non – addicted cohorts.

<p>Location of the cutaneous leishmaniasis lesions in opium addicted and opium non – addicted cohorts.</p